Heart failure: B-QuiCK

B-QuiCK: Heart Failure

0 comments

save

feedback

Choose another topic

Heart failure

Summary: Diagnosing patients with heart failure in primary care

Summary: Managing patients with heart failure in primary care

N.B. The approach of using an ACE inhibitor first-line before trialling an ARB (if the ACE inhibitor is contraindicated or not tolerated) is consistent with 2018 National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand Heart Failure guidelines. However, in the 2022 AHA/ACC/HFSA Heart Failure guidelines from the United States ACE inhibitors, ARBs and ARNIs are all now considered first-line options. It is possible that New Zealand guidance may change over time.

It is strongly recommended to review the original resources at your convenience for full details of recommendations and evidence.

See full articles here: Addressing heart failure in primary care

Comment features

You can add replies to a comment. Simply click the "Reply to comment" button and complete the form. Your reply, once approved, will appear below the comment to which you replied (if there are multiple replies to a comment, they will appear in order of submission).

You can add a new comment by scrolling to the bottom of the discussion and clicking the "Add a comment" button.

If someone adds a reply to one of your comments (or replies) you will receive an email notifying you of this. You can opt out of (or into if currently out) all comment notification emails by clicking the button below.

There are currently no comments for this article.

Please login to make a comment.

CPD information

Prescribing Reports

Audits

CME Quizzes

Peer Group Discussions

My Bpac account

B-QuiCK: Heart Failure

Heart failure

Summary: Diagnosing patients with heart failure in primary care

Summary: Managing patients with heart failure in primary care

Comment features

Discussion

Partner links